Twister Biotech Overview

  • Founded
  • 2013

  • Status
  • Private

  • Employees
  • 2

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.12M

  • Investors
  • 1

Twister Biotech General Information


Developer of gene therapies intended to treat rare cancers and autoimmune diseases using a proprietary platform. The company's gene therapies are a result of research, development, and commercialization of supercoiled DNA minicircles for transfer of DNA into primary and stem cells, enabling researchers to get better transfection efficiencies and long-term effects and also that are easily delivered for safer, effective gene and cell therapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Primary Office
  • Post Office Box 20566
  • Houston, TX 77225
  • United States
+1 (713) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Twister Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 11-Jan-2021 $1.12M 00.000 00.000 Completed Pre-Clinical Trials
To view Twister Biotech’s complete valuation and funding history, request access »

Twister Biotech Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view Twister Biotech’s complete cap table history, request access »

Twister Biotech Executive Team (4)

Name Title Board Seat Contact Info
Lynn Zechiedrich Ph.D Co-Founder, Chief Scientific Officer & Board Member
Jamie Catanese Ph.D Co-Founder & Scientific Advisor
Christopher Coker Chief Executive Officer, President & Board Member
You’re viewing 3 of 4 executive team members. Get the full list »

Twister Biotech Board Members (2)

Name Representing Role Since
Lynn Zechiedrich Ph.D Twister Biotech Co-Founder, Chief Scientific Officer & Board Member 000 0000
Mark Matovich Twister Biotech Board Member 000 0000
To view Twister Biotech’s complete board members history, request access »

Twister Biotech Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Twister Biotech Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BCM Technologies Venture Capital Minority 000 0000 000000 0
To view Twister Biotech’s complete investors history, request access »